LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Learn More About ARCA biopharma (NASDAQ: ABIO)
ARCA biopharma (NASDAQ: ABIO)
image
A pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation (AF) in patients with heart failure and reduced left ventricular ejection fraction (HFREF)
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next